Stock Price, News, Quote and Profile of CLEARMIND MEDICINE INC(NASDAQ:CMND) stock

CLEARMIND MEDICINE INC

NASDAQ:CMND (12/20/2024, 8:02:54 PM)

1.2

+0.01 (+0.84%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryPharmaceuticals

GICS SubIndustryPharmaceuticals

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%75.84%

Sales Q2Q%N/A

CRS10.54

6 Month-17.24%

Overview

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Ins Owners5.63%

Inst Owners7.17%

Market Cap5.26M

Shares4.38M

PEN/A

Fwd PEN/A

Dividend YieldN/A

AnalystsN/A

Short Float %4.72%

Short Ratio0.6

IPO08-10 2021-08-10

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.

Company Info

CLEARMIND MEDICINE INC

101-1220 West 6Th Avenue

Vancouver BRITISH COLUMBIA

P: 16042601566

Employees: 0

Website: https://www.clearmindmedicine.com/

CMND News

6 days ago - Clearmind Medicine Inc.Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind...

2 months ago - Clearmind Medicine Inc.Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

FDA approval for the IND submission to conduct its trial already secured Vancouver, Canada, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc....

3 months ago - Clearmind Medicine Inc.Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Innovative drug treatment developed in collaboration with SciSparc aims to enhance safety and efficacy in mental health and addiction care Vancouver,...

CLEARMIND MEDICINE INC (CMND)

Nasdaq Stock Screener

USA Stock Screener